Anaphylaxis inhibitory factor in IgE-dependent mast cell stimulation.

Area of Science:

• Immunology
• Cell Biology

Background:

• Immunoglobulin E (IgE)-mediated reactions are central to immediate hypersensitivity.
• Mast cells play a critical role in allergic responses through degranulation and mediator release.
• Tumor necrosis factor-alpha (TNF-alpha) is a key cytokine released by mast cells during anaphylaxis.

Purpose of the Study:

• To investigate the effect of a previously identified human serum anaphylaxis inhibitory factor on IgE-dependent mast cell TNF-alpha release.
• To determine the impact of this factor on mast cell degranulation.

Main Methods:

• Rat peritoneal mast cells and RBL-2H3 cells were sensitized with monoclonal IgE anti-dinitrophenol (anti-DNP).
• Cells were challenged with dinitrophenol-bovine serum albumin (DNP-BSA) to induce IgE-dependent activation.
• TNF-alpha release and mast cell degranulation were measured at various time points.
• The inhibitory factor's effect was assessed when pre-incubated with IgE or mast cells before antigen challenge.

Main Results:

• Optimal TNF-alpha release occurred at 30 minutes post-challenge in both cell types.
• The human serum inhibitory factor significantly inhibited TNF-alpha release and reduced mast cell degranulation when applied before antigen challenge.
• Pre-incubation of mast cells with the factor alone did not induce TNF-alpha release but increased degranulation via a non-IgE-dependent pathway.

Conclusions:

• The human serum anaphylaxis inhibitory factor effectively suppresses IgE-dependent TNF-alpha release and degranulation in mast cells.
• The factor may modulate both immediate hypersensitivity and later-phase allergic inflammatory responses.